6 completed, 1 active not recruiting. 7 Phase 3, 1 Phase 2.
By phase and status
Follow Cobicistat: new trials by email Literature Review of Cobicistat trials Research Report on Cobicistat
Trials (filtered) newest first · largest first
All 7 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults
RTV, ATV, DRV - HIV-1 Infection | Phase 3 | Completed | 578 | 2015-11-20 | 2020-12-29 |
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV
ATV, DRV, Cobicistat - Acquired Immune Deficiency Syndrome (AIDS), HIV Infections | Phase 2 / Phase 3 | Active not recruiting | 133 | 2014-01-16 | 2026-04-21 |
Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants
E/C/F/TAF, E/C/F/TDF, EFV/FTC/TDF - HIV, HIV Infections | Phase 3 | Completed | 1443 | 2013-03-27 | 2021-04-13 |
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
COBI, DRV, NRTIs - Acquired Immunodeficiency Syndrome, HIV Infections | Phase 3 | Completed | 314 | 2011-09-01 | 2016-12-14 |
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
E/C/F/TDF, COBI, ATV - Acquired Immunodeficiency Syndrome, HIV Infections | Phase 3 | Completed | 106 | 2011-05-01 | 2016-05-02 |
Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
COBI, RTV, ATV - HIV, HIV Infections | Phase 3 | Completed | 698 | 2010-04-01 | 2016-05-23 |
A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women
Darunavir, Ritonavir, Etravirine - HIV, HIV Infections | Phase 3 | Completed | 77 | 2009-04-09 | 2018-07-06 |
Conditions studied
HIV Infections (6) · Acquired Immunodeficiency Syndrome (4)
Sponsors
Gilead Sciences (6) · Janssen Scientific Affairs, LLC (1)
Countries
United States (7) · Puerto Rico (6) · United Kingdom (5) · Australia (4) · Canada (4) · Dominican Republic (4) · Germany (4) · Austria (3) · Belgium (3) · France (3) · Italy (3) · Mexico (3) · Spain (3) · Thailand (3) · Brazil (2)
Top investigators
Huyen Cao, MD (1) · Javier Szwarcberg, MD (1) · Marshall Fordyce, MD (1)
Results publications
PMID 23532097, PMID 25397568, PMID 25469527, PMID 26181707, PMID 26538525, PMID 27774892, PMID 28259777, PMID 29335895, PMID 29368537, PMID 29925490, PMID 30932951, PMID 31303140, PMID 31430369, PMID 31826005, PMID 36912172
NIH funding
2009 (1), 2015 (1)